WORLAND STEPHEN T 4
4 · eFFECTOR Therapeutics, Inc. · Filed Jan 24, 2022
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Stock Option (Right to Buy)
2022-01-20+520,674→ 520,674 totalExercise: $6.65Exp: 2032-01-19→ Common Stock (520,674 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of January 20, 2022 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.